Intra-Cellular Therapies Inc. (ITCI) SEC filings
ITCI SEC filings moved a median of -0.01% by the close. ITCI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ITCI overview →
41 measured ITCI SEC filing events.
Where these ITCI SEC filings landedvs 35 measured ITCI SEC filing reactions
| Middle 50% of ITCI SEC filing reactions | -0.76% to +2.14% |
|---|---|
| Median reaction (to close) | -0.01% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 ITCI SEC filing events with a measured close landed between -0.76% and +2.14%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Intra-Cellular Therapies | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Intra-Cellular Therapies | SEC filing · Form EFFECT | — | — | |
| Form 8-K Intra-Cellular Therapies For: Apr 02 | SEC filing · Form 8-K | — | — | |
| Form POS AM Intra-Cellular Therapies | SEC filing · Form POS | — | — | |
| Form POSASR Intra-Cellular Therapies | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Intra-Cellular Therapies | SEC filing · Form S-8 | — | — | |
| Form 8-K Intra-Cellular Therapies For: Mar 27 | SEC filing · Form 8-K | +0.01% | -0.03% | |
| Form 10-K/A Intra-Cellular Therapies For: Dec 31 | SEC filing · Form 10-K | +0.04% | +0.08% | |
| Form 8-K Intra-Cellular Therapies For: Mar 18 | SEC filing · Form 8-K | +0.06% | +0.06% | |
| Form 8-K Intra-Cellular Therapies For: Feb 26 | SEC filing · Form 8-K | -0.00% | -0.05% | |
| Form 10-K Intra-Cellular Therapies For: Dec 31 | SEC filing · Form 10-K | -0.02% | -0.01% | |
| Form 8-K Intra-Cellular Therapies For: Feb 21 | SEC filing · Form 8-K | -0.02% | -0.01% | |
| Form DEFM14A Intra-Cellular Therapies | SEC filing · Form DEFM14A | +0.20% | +0.45% | |
| Form PREM14A Intra-Cellular Therapies For: Feb 05 | SEC filing · Form PREM14A | +0.14% | +0.03% | |
| Form 8-K Intra-Cellular Therapies For: Jan 10 | SEC filing · Form 8-K | -0.19% | -0.61% | |
| Form DEFA14A Intra-Cellular Therapies | SEC filing · Form DEFA14A | -0.19% | -0.61% | |
| Form 8-K Intra-Cellular Therapies For: Jan 08 | SEC filing · Form 8-K | +8.75% | +9.64% | |
| Form 8-K Intra-Cellular Therapies For: Dec 03 | SEC filing · Form 8-K | -0.58% | -0.81% | |
| Form 8-K Intra-Cellular Therapies For: Nov 05 | SEC filing · Form 8-K | +0.46% | +4.02% | |
| Form 10-Q Intra-Cellular Therapies For: Sep 30 | SEC filing · Form 10-Q | +7.11% | +8.34% | |
| Form 8-K Intra-Cellular Therapies For: Oct 30 | SEC filing · Form 8-K | +7.11% | +8.34% | |
| Form 10-Q Intra-Cellular Therapies For: Jun 30 | SEC filing · Form 10-Q | -1.76% | -4.31% | |
| Form 8-K Intra-Cellular Therapies For: Aug 02 | SEC filing · Form 8-K | -1.76% | -4.31% | |
| Form S-8 Intra-Cellular Therapies | SEC filing · Form S-8 | +0.06% | -0.80% | |
| Form 8-K Intra-Cellular Therapies For: Jun 14 | SEC filing · Form 8-K | -0.67% | +0.42% | |
| Form 8-K Intra-Cellular Therapies For: Jun 18 | SEC filing · Form 8-K | -2.29% | -0.78% | |
| Form 10-Q Intra-Cellular Therapies For: Mar 31 | SEC filing · Form 10-Q | +0.22% | +2.14% | |
| Form 8-K Intra-Cellular Therapies For: May 07 | SEC filing · Form 8-K | +0.22% | +2.14% | |
| Form ARS Intra-Cellular Therapies For: Dec 31 | SEC filing · Form ARS | +0.03% | -0.88% | |
| Form DEF 14A Intra-Cellular Therapies For: Dec 31 | SEC filing · Form DEF | +0.03% | -0.88% | |
| Form DEFA14A Intra-Cellular Therapies | SEC filing · Form DEFA14A | +0.03% | -0.88% | |
| Form 8-K Intra-Cellular Therapies For: Apr 22 | SEC filing · Form 8-K | -0.85% | -0.46% | |
| Form 8-K Intra-Cellular Therapies For: Apr 17 | SEC filing · Form 8-K | +0.35% | +0.08% | |
| Form 8-K Intra-Cellular Therapies For: Apr 16 | SEC filing · Form 8-K | +4.01% | +6.04% | |
| Form S-3ASR Intra-Cellular Therapies | SEC filing · Form S-3ASR | -3.14% | -2.92% | |
| Form 8-K Intra-Cellular Therapies For: Mar 27 | SEC filing · Form 8-K | -0.40% | -0.40% | |
| Form 8-K Intra-Cellular Therapies For: Mar 14 | SEC filing · Form 8-K | +1.02% | +2.41% | |
| Form 10-K Intra-Cellular Therapies For: Dec 31 | SEC filing · Form 10-K | -0.09% | +2.25% | |
| Form 8-K Intra-Cellular Therapies For: Feb 22 | SEC filing · Form 8-K | -0.09% | +2.25% | |
| Form 10-Q Intra-Cellular Therapies For: Sep 30 | SEC filing · Form 10-Q | +1.68% | -0.74% | |
| Form 8-K Intra-Cellular Therapies For: Nov 02 | SEC filing · Form 8-K | +1.68% | -0.74% |
Keep exploring
More ITCI: earnings → · analyst actions → · ITCI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MELINTA THERAPEUTICS INC (MLNT) | 248 | -0.38% | 34% |
| Heron Therapeutics, Inc. (HRTX) | 247 | -0.34% | 42% |
| Avadel Pharmaceuticals plc - Ordinary Share (AVDL) | 246 | -0.16% | 42% |
| Cumberland Pharmaceuticals Inc. (CPIX) | 245 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.